These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3115076)

  • 21. Schistosoma mansoni: the circulating cathodic antigen forms an abundant product of 41/42 kDa in the urine of infected patients.
    Abdeen HH; Attallah AF; El-Mohamady HI; Harrison RA; Mansour MM
    Exp Parasitol; 1998 Nov; 90(3):286-9. PubMed ID: 9806874
    [No Abstract]   [Full Text] [Related]  

  • 22. Development of a radioimmunoassay for the immunodiagnosis of schistosomiasis mansoni.
    Hillyer GV; Soler de Galanes M
    Bol Asoc Med P R; 1986 Oct; 78(10):431-3. PubMed ID: 3098258
    [No Abstract]   [Full Text] [Related]  

  • 23. Substance P and somatostatin can modulate the amount of IgG2a secreted in response to schistosome egg antigens in murine schistosomiasis mansoni.
    Blum AM; Metwali A; Mathew RC; Elliott D; Weinstock JV
    J Immunol; 1993 Dec; 151(12):6994-7004. PubMed ID: 7505019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a vaccine strategy against human and bovine schistosomiasis. Background and update.
    Capron A; Riveau G; Grzych JM; Boulanger D; Capron M; Pierce R
    Trop Geogr Med; 1994; 46(4 Spec No):242-6. PubMed ID: 7825228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Schistosoma mansoni infection in humans and primates induces cytolytic antibodies to surface Le(x) determinants on myeloid cells.
    Nyame AK; Pilcher JB; Tsang VC; Cummings RD
    Exp Parasitol; 1996 Mar; 82(2):191-200. PubMed ID: 8617346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The blocking of human antibody-dependent, eosinophil-mediated killing of Schistosoma mansoni schistosomula by monoclonal antibodies which cross-react with a polysaccharide-containing egg antigen.
    Dunne DW; Bickle QD; Butterworth AE; Richardson BA
    Parasitology; 1987 Apr; 94 ( Pt 2)():269-80. PubMed ID: 3588013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective antigens in experimental schistosomiasis.
    Capron A; Pierce R; Balloul JM; Grzych JM; Dissous C; Sondermeyer P; Lecocq JP
    Acta Trop Suppl; 1987 Jun; 12():63-9. PubMed ID: 2442987
    [No Abstract]   [Full Text] [Related]  

  • 28. Human immunity to Schistosoma mansoni: observations on mechanisms, and implications for control.
    Butterworth AE; Dunne DW; Fulford AJ; Thorne KJ; Gachuhi K; Ouma JH; Sturrock RF
    Immunol Invest; 1992 Aug; 21(5):391-407. PubMed ID: 1428017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IgG4 and IgE responses to Schistosoma mansoni adult worms after treatment.
    Webster M; Fallon PG; Fulford AJ; Butterworth AE; Ouma JH; Kimani G; Dunne DW
    J Infect Dis; 1997 Feb; 175(2):493-4. PubMed ID: 9203682
    [No Abstract]   [Full Text] [Related]  

  • 30. Predominance of IgA deposits in glomeruli of Schistosoma mansoni infected mice.
    el-Sherif AK; Befus D
    Clin Exp Immunol; 1988 Jan; 71(1):39-44. PubMed ID: 3127090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of resistance against Schistosoma mansoni infection by passive transfer of an IgG2a monoclonal antibody.
    Attallah AM; Attia H; El-Nashar EM; Nawar A; Abdel Kader K; Ismail H; El Ebeidy G
    Vaccine; 1999 May; 17(18):2306-10. PubMed ID: 10403599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IgE and IgG4 antibodies in subjects reinfected with Schistosoma mansoni in an endemic area of northeast Brazil.
    Gomes YM; Gomes FC; Furtado VC; Teixeira KM; Souza WV; Abath FG
    Mem Inst Oswaldo Cruz; 1998; 93 Suppl 1():183-4. PubMed ID: 9921346
    [No Abstract]   [Full Text] [Related]  

  • 33. Recent advances in vaccine research against schistosomiasis in Brazil.
    Oliveira SC; Fonseca CT; Cardoso FC; Farias LP; Leite LC
    Acta Trop; 2008; 108(2-3):256-62. PubMed ID: 18577363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunity in human schistosomiasis.
    Butterworth AE
    Acta Trop Suppl; 1987 Jun; 12():31-40. PubMed ID: 3115074
    [No Abstract]   [Full Text] [Related]  

  • 35. Induction of cell-mediated immunity as a strategy for vaccination against Schistosoma mansoni.
    James SL; Pearce EJ; Lanar D; Sher A
    Acta Trop Suppl; 1987 Jun; 12():50-4. PubMed ID: 3115075
    [No Abstract]   [Full Text] [Related]  

  • 36. Schistosoma spp.: progress toward a defined vaccine.
    James SL
    Exp Parasitol; 1987 Jun; 63(3):247-52. PubMed ID: 3108024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of IgM antibodies directed against the gut-associated circulating cathodic antigen in sera from Schistosoma mansoni infected patients. Development and comparison of three enzyme-linked immunoassays.
    van Dam GJ; Qian ZL; Fillié YE; Rotmans JP; Deelder AM
    Trop Geogr Med; 1993; 45(2):59-65. PubMed ID: 8511812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Schistosoma mansoni: protective antigens.
    Tendler M
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():125-8. PubMed ID: 3151086
    [No Abstract]   [Full Text] [Related]  

  • 39. Schistosoma mansoni: analysis of monoclonal antibodies reactive with gut-associated antigens.
    van Dam GJ; Kornelis D; Van Zeyl RJ; Rotmans JP; Deelder AM
    Parasitol Res; 1993; 79(1):55-62. PubMed ID: 7682328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination against Schistosoma mansoni with purified surface antigens.
    Smith MA; Clegg JA
    Science; 1985 Feb; 227(4686):535-8. PubMed ID: 3966161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.